Drug intelligence / Profile preview

choline alfoscerate + piracetam

Development stage
Unknown
Lead developer
Primus Remedies
Modality
Small Molecules
Administration
Oral
01

Overview

Pizalin is a fixed-dose combination of choline alfoscerate (alpha-GPC) and piracetam, developed by Primus Remedies. It is used as a cognitive enhancer to improve memory, attention, and overall brain function in patients with cognitive decline, dementia, Alzheimer's disease, or recovering from stroke or head injury. Choline alfoscerate acts as a highly bioavailable precursor to acetylcholine, increasing its levels in the brain to support memory and learning. Piracetam, a nootropic agent, enhances neuronal communication, improves membrane fluidity, and increases the activity of acetylcholine and other neurotransmitters. Together, they work synergistically to provide neuroprotection and support cognitive rehabilitation.

Brand names
Pizalin
Other names
alpha-GPC + piracetamalpha-glycerylphosphorylcholine + piracetamcholine alphoscerate + piracetam
02

Targets

AMPAR (AMPA receptor)mAChR (Muscarinic acetylcholine receptors)Nicotinic Acetylcholine ReceptorCaV (Voltage-gated calcium channel protein complex)

Beyond the preview

Go deeper on choline alfoscerate + piracetam.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on choline alfoscerate + piracetam.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call